Delivery Order SPE2DB22D3501-SPE2DB25FWS63
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Ramelteon 8 mg tablets in unit-dose packaging (50-count) valued at $2,315.08. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a competitive award with no set-aside designation. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its...
- This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,177,965 units of the sleep medication Ramelteon 8 mg Tablet 30s. The $1,415.04 contract has a performance period through May 8, 2025 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a comprehensive global...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at approximately $512 to Amerisourcebergen Drug Corporation. The order is for 4561773723, which is Ramelteon 8 mg tablets, with a quantity of 30 units. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is August 10-11, 2023. No major subcontractors or set aside designations were identified. The Defense Logistics Agency supports America's armed...
- The Defense Logistics Agency awarded a delivery order valued at $394.39 to Amerisourcebergen Drug Corporation for the supply of 4561543359 Ramelteon 8 mg tablets. As the prime contractor, Amerisourcebergen will deliver 100 units of the specified pharmaceutical product to a facility in Conshohocken, Pennsylvania under a firm fixed price contract executed on July 19, 2023 for completion by July 20, 2023. No subcontractors or set aside designations were indicated. The Defense Logistics Agency...
- The Defense Logistics Agency awarded a $29,160 delivery order to Amerisourcebergen Drug Corporation for 30 boxes of 8 mg Ramelteon tablets. The firm fixed price order is being fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with performance spanning July 21-24, 2023. No subcontractors or set aside designations were specified. The Defense Logistics Agency manages the Department of Defense's global supply chain and works to ensure medical supplies and pharmaceuticals are...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $1,122 to Amerisourcebergen Drug Corporation. The order is for 30 packages of 8mg Ramelteon tablets to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania by September 7, 2023. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, will perform as the prime contractor under this order placed against an existing DLA contract vehicle. No set aside designation or...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The $1,543.17 firm fixed price delivery order is for the supply of RAMELTEON 8 MG TABLET UD 50S, a pharmaceutical product. The contract has an ultimate completion date of May 20, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $364.25 to Amerisourcebergen Drug Corporation. Under the contract, Amerisourcebergen will provide 100 boxes of 8mg Ramelteon tablets to support the Department of Defense's medical supply needs. As the prime contractor, Amerisourcebergen will leverage its corporate infrastructure and distribution network based in Conshohocken, Pennsylvania to fulfill delivery of the pharmaceutical products to the customer by July 11,...
- This firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $1,511.45 contract is for the provision of 30-count tablets of the pharmaceutical drug Ramelteon 8 mg. The delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is a leading global pharmaceutical sourcing and distribution services company that has received numerous federal contract awards from DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,286.88, to provide RAMELTEON 8 MG TABLET 100S to the government. The contract has an ultimate completion date of July 11, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FWS63Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Ramelteon 8 mg tablets in unit dose packaging (50 count) with a firm fixed price ceiling value of $2,669.48. This non-set-aside competitive award is scheduled for completion by August 5, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, was selected to fulfill this pharmaceutical supply requirement for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a wide range of pharmaceutical products and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The Defense Logistics Agency is planning to establish Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, positioning AmerisourceBergen Drug Corp to continue serving critical federal healthcare customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.7k | 8/4/25 |